MORGAN STANLEY: Here are the 10 healthcare companies most likely to get bought this year AP
Allergan is among the healthcare companies Morgan Stanley sees as a possible M&A target.
It's shaping up to be a big year for healthcare M&A.
In the month of January alone, there was a total of
$27.5 billion worth of deals
, including a
$9 billion deal
for a cancer drugmaker and a bidding war for a
US tax reform has
freed up a lot of cash companies had overseas
- cash that might be spent on more acquisitions to boost their businesses.
While it's easy to determine who might be in
the mood to do some acquiring, spotting the targets can be a bit more difficult.
To help out,
compiled a list of large and liquid companies it thinks will get at least one tender offer over the next 12 months. While the Morgan Stanley note contained 21 companies, we stuck to just the top 10 by market cap and trading volume.
Company summary: Mylan, known for its generic drug business and as the maker of the EpiPen, got a boost in October 2017 when the FDA approved its generic version of the multiple sclerosis drug Copaxone. Market cap: $22.7 billion Iqvia Holdings
Company summary: Iqvia, formerly known as Quintiles IMS Holdings, does both clinical trials for pharmaceutical companies and analyzes industry data. It's one of the largest contract research organizations, companies that have been going through a lot of M&A. Market cap: $23.1 billion Advertisement Edwards Lifesciences
Company summary: Edwards Lifesciences is a medical device company that makes heart valves and other devices used in surgical procedures. Market cap: $23.8 billion Zimmer Biomet
Company summary: Zimmer Biomet is a medical device company that makes products used in knee and hip replacements and other surgical procedures. Market cap: $24.4 billion Advertisement Alexion Pharmaceuticals
Company summary: Alexion, a rare disease drugmaker, has been under pressure from activist investors to get its stock up, and both its CEO and CFO left the company in 2017. Market cap: $26.6 billion HCA Healthcare
Company summary: HCA, an acronym for Hospital Corporation of America, operates 177 hospitals and 119 surgery centers in the US and the UK and other facility-based companies. Market cap: $31.3 billion Advertisement Illumina
Company summary: Gene-sequencing company Illumina makes technology that has drastically brought down the cost of reading all the information in your genome. Market cap: $31.9 billion Boston Scientific
Company summary: Boston Scientific is a medical device company known for its pacemakers and medical equipment. Market cap: $34 billion Advertisement Express Scripts
Company summary: Express Scripts is pharmacy benefits manager, or a company that negotiates discounts to drug prices for health plans in the form of rebates. Express Scripts is the largest standalone PBM, and its stock has been weathering news that Amazon is interested in getting into healthcare. Market cap: $42.2 billion Allergan
Company summary: Allergan, the drugmaker behind Botox, had an interesting 2017. The company struck an unusual deal with the Saint Regis Mohawk Tribe to transfer patents of the eye drug Restasis. The move drew a lot of backlash. Market cap: $54.4 billion Advertisement